CTLA-4/CD152[Biotin], His & Avi, Human
¥3300 | |
Z04436-100 | |
|
|
|
|
|
¥3300 | |
Z04436-100 | |
|
|
|
|
|
Species | Human | ||||||
Protein Construction |
|
||||||
Conjugate | Biotin | ||||||
Purity |
> 95% as determined by BisTris PAGE > 95% as determined by HPLC |
||||||
Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||||
Biological Activity | Measured by its binding ability in a functional ELISA. Immobilized CTLA-4/CD152[Biotin], His & Avi, Human at 1μg/ml (100μl/well) on the streptavidin precoated plate (5μg/ml) can bind Human B71, hFc Tag. Test result was comparable to standard batch. | ||||||
Expression System | HEK293 | ||||||
Theoretical Molecular Weight | 16.3 kDa | ||||||
Apparent Molecular Weight | Due to glycosylation, the protein migrates to 25-30 kDa based on Bis-Tris PAGE result. | ||||||
Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||||
Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||||
Storage & Stability | Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
Immobilized CTLA-4/CD152[Biotin], His & Avi, Human His Tag at 1 μg/ml (100 μl/well) on the streptavidin precoated plate(5 μg/ml). Dose response curve for Human B7-1, hFc Tag with the EC50 of 2.4 ng/ml determined by ELISA. »
Immobilized Anti-CTLA-4 Antibody, hFc Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for CTLA-4/CD152[Biotin], His & Avi, Human, His Tag with the EC50 of 45.7 ng/ml determined by ELISA. »
The purity of CTLA-4/CD152[Biotin], His & Avi, Human is greater than 95% as determined by SEC-HPLC. »
CTLA-4/CD152[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
Target Background | CTLA-4 (cytotoxic T-lymphocyte-associated protein 4), also known as CD152, is a protein receptor that, functioning as an immune checkpoint, downregulates immune responses.CTLA4 is constitutively expressed in regulatory T cells but only upregulated in conventional T cells after activation – a phenomenon which is particularly notable in cancers. It acts as an 'off' switch when bound to CD80 or CD86 on the surface of antigen-presenting cells. |
Synonyms | CTLA4; CD152; ICOS; CELIAC3; GRD4; GSE; ALPS5; IDDM12 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.